Hahnemann Pharmaceuticals Private Limited, a active private limited company, was established on 14 July 1996 in New Delhi, Delhi, India. Engaging in alternative & holistic medicine within the manufacturing sector, it holds CIN: U24232DL1996PTC080135. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹2.00 M and a paid-up capital of ₹0.49 M.
It upholds a compliant status. Its leadership includes Neeru Narula (Director), Karan Narula (Additional Director), Pooja Narula (Director). It holds ₹8.30 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at A-7 Naraina Industrial Area Phase-I, New Delhi, Delhi, 110028.
U24232DL1996PTC080135
080135
14 July 1996
₹2.00 M
₹0.49 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Hahnemann Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Neeru Narula | Director | 14 Jul 1996 | Current |
| Karan Narula | Additional Director | 02 Sep 2019 | Current |
| Pooja Narula | Director | 14 Jul 1996 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Hahnemann Pharmaceuticals Private Limited, for the financial year ended 2017, experienced Minor drop in revenue, with a 1.02% decrease. The company also saw a substantial fall in profitability, with a 69.44% decrease in profit. The company's net worth observed a substantial decline by a decrease of 10.4%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2017, Hahnemann Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹8,300,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Mar 2005 | Bank Of India | ₹5.30 M | Open |
| 20 Dec 2002 | The Jammu & Kashmir Bank Ltd. | ₹1.60 M | Open |
| 06 Jan 2000 | Uco Bank | ₹0.50 M | Open |
| 11 Sep 1997 | Union Bank Of India | ₹0.90 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Hahnemann Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Hahnemann Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hahnemann Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Hahnemann Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Hahnemann Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was recorded as a recent event.
The activity Karan Narula was appointed as a Additional Director was appointed as a Additional Director on 02 Sep 2019 & has been associated with this company since 6 years 2 months . was completed.
A charge with Bank Of India amounted to Rs. 5.30 M with Charge ID 90059013 was registered on 29 Mar 2005. was recorded as a recent event.
Progress on A charge with The Jammu & Kashmir Bank Ltd. amounted to Rs. 1.60 M with Charge ID 90057944 was registered on 20 Dec 2002. was documented.
Progress on A charge with Uco Bank amounted to Rs. 0.50 M with Charge ID 90057164 was registered on 06 Jan 2000. was documented.
The CIN of Hahnemann Pharmaceuticals Private Limited is U24232DL1996PTC080135.
Hahnemann Pharmaceuticals Private Limited is headquartered at A-7 Naraina Industrial Area Phase-I, New Delhi, Delhi, 110028.
Hahnemann Pharmaceuticals Private Limited was incorporated on 14 July 1996.
The current directors of Hahnemann Pharmaceuticals Private Limited are
The primary industry of Hahnemann Pharmaceuticals Private Limited is Manufacturing.
Hahnemann Pharmaceuticals Private Limited is unlisted.
The authorized capital of Hahnemann Pharmaceuticals Private Limited is ₹2.00 M, and the paid-up capital is ₹0.49 M.
The compliance status of Hahnemann Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX